Amy W. Schulman
Chief Executive Officer and board member of Arsia Therapeutics; co-founder, President and Chief Executive Officer of Lyndra, Inc.; Venture Partner at Polaris Partners; Former Executive Vice President and General Counsel of Pfizer Inc.; served as the Business Unit Lead for Pfizer’s Consumer Healthcare business; senior lecturer at Harvard Business School; director of BIND Therapeutics, Inc. and Blue Buffalo Pet Products, Inc.